Showing results (371-380 of 612) with videos related to

Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 19, 2021
Expanded access to multiple sclerosis teleneurology care following the COVID-19 pandemicMarisa P McGinley, Shauna Gales, William Rowles, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 15, 2021
EMDR treatment for anxiety in MS patients: A pilot studyOlga C Wallis, Jolanda de Vries
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2021
Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insightsMarc Bigaud, Bettina Rudolph, Emmanuelle Briard, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related ReactionsEnrique Alvarez, Kavita V Nair, Stefan Sillau, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metricsCarrie M Hersh, Arman Altincatal, Nicholas Belviso, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head ImagesKamyar Taheri, Irene M Vavasour, Shawna Abel, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Let's talk about sex(ual) wellbeing! Staff perceptions of implementing a novel service for people with Multiple SclerosisLaura Jarvis, Kevin McConville, Sonia Devereux, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 10, 2022
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort studyMaria Antonella Zingaropoli, Patrizia Pasculli, Marco Iannetta, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Diagnostic value of gadolinium contrast administration for spinal cord magnetic resonance imaging in multiple sclerosis patients and correlative markers of lesion enhancementKianush Karimian-Jazi, Ulf Neuberger, Katharina Schregel, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disordersVyanka Redenbaugh, Mayra Montalvo, Elia Sechi, et al.
Pageof 62